Disclosed positions

Estimated from their latest filings — positions may have changed since

$5.16M

combined est. value

Stock	Shares	Price	Value	Weight	As of
MDGLMADRIGAL PHARMACEUTICALS, INC.	9,122	$565.40	$5.16M	100%	2026-01-26

MDGL

MADRIGAL PHARMACEUTICALS, INC.

$5.16M

9,122 sh

All filings on record

Every Form 4 transaction we track for this filer

all 13buys 0sells 13

Stock	Transaction	Date	~6mo later
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $281.9K · 570 sh	2026-01-26	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $167.4K · 340 sh	2026-01-26	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $45.2K · 80 sh	2025-11-21	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $22.5K · 40 sh	2025-11-21	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $44.8K · 80 sh	2025-11-21	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $111.9K · 200 sh	2025-11-21	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $66.7K · 120 sh	2025-11-21	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $22.1K · 40 sh	2025-11-21	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $110.5K · 200 sh	2025-11-21	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $22.0K · 40 sh	2025-11-21	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $65.8K · 120 sh	2025-11-21	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $78.8K · 144 sh	2025-11-21	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $492.6K · 894 sh	2025-11-21	—

MDGLSell

2026-01-26 · MADRIGAL PHARMACEUTICALS, INC.

$281.9K

—

MDGLSell

2026-01-26 · MADRIGAL PHARMACEUTICALS, INC.

$167.4K

—

MDGLSell

2025-11-21 · MADRIGAL PHARMACEUTICALS, INC.

$45.2K

—

MDGLSell

2025-11-21 · MADRIGAL PHARMACEUTICALS, INC.

$22.5K

—

MDGLSell

2025-11-21 · MADRIGAL PHARMACEUTICALS, INC.

$44.8K

—

MDGLSell

2025-11-21 · MADRIGAL PHARMACEUTICALS, INC.

$111.9K

—

MDGLSell

2025-11-21 · MADRIGAL PHARMACEUTICALS, INC.

$66.7K

—

MDGLSell

2025-11-21 · MADRIGAL PHARMACEUTICALS, INC.

$22.1K

—

MDGLSell

2025-11-21 · MADRIGAL PHARMACEUTICALS, INC.

$110.5K

—

MDGLSell

2025-11-21 · MADRIGAL PHARMACEUTICALS, INC.

$22.0K

—

MDGLSell

2025-11-21 · MADRIGAL PHARMACEUTICALS, INC.

$65.8K

—

MDGLSell

2025-11-21 · MADRIGAL PHARMACEUTICALS, INC.

$78.8K

—

MDGLSell

2025-11-21 · MADRIGAL PHARMACEUTICALS, INC.

$492.6K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.